Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer

Table 1 Demographic data of 7 patients

Patient No.	Age (yr)/Sex	Latent time (mo)	GTV (mL)	Dose (Gy)	Prescribed isodose (%)	Dmax of intestine (Gy)	V45 (mL)	Failure pattern	F/U (mo)	Final status
1	63/M	9	20	36	83	33	0	Lt SCLN (23)	70	AWD
								Lung (32)
2	64/F	44	4	41	82	38	0	-	37	Died due to lymphoma
3	52/F	29	24	45	78	48	0.2	Spine (26)	41	DOD
4	59/M	21	22	48	80	51	0.7	Lung (7)	22	DOD
5	56/M	10	9	48	80	40	0	PALN(9)	21	AWD
6	47/M	18	40	48	76	53	3.6	Rectum (7)	25	DOD
								Lt SCLN (7)
								Peritoneal seeding (25)
								Local recur (13)
7	73/M	7	29	51	78	50	0.9	-	26	CDF

GTV: Gross tumor volume; AWD: Alive with disease; CDF: Continuously disease-free; DOD: Died of disease; Latent time: Disease free interval from operation to first relapse; F/U: Follow-up from commencement of SBRT to last follow-up or death; Lt SCLN: Left supraclavicular lymph node; Dmax: Maximum point dose of intestine; V45: Intestinal volume receiving 45 Gy or more; Vpre: Total volume receiving the prescribed dose or more; Parenthesis (mo) means the period from SBRT to detection of complication.